Terry Speed has joined the scientific advisory board of Bionovo, a cancer drug development company. Speed is a professor in the department of statistics at the University of California, Berkeley, and senior principal research scientist and head of the bioinformatics division of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. Speed has served as a consultant to Stillwater Sciences, Genedata, Gene Logic, and Affymetrix.
Hans-Joachim Bohm has been appointed president of Roche Palo Alto. Bohm will manage early discovery in three of Roche's therapy areas: virology; neurosciences; and autoimmunity, inflammation, and transplantation. Bohm was most recently director of safety and technical sciences for Roche in Basel, Switzerland. He joined Roche Basel in 1996 as head of molecular design and bioinformatics, and since then has held a series of positions within the organization. Bohm succeeds Robert Stein, who has taken another position within the company.